Resmed (RMD) Change in Accured Expenses (2009 - 2026)

Resmed's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $103.9 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 64.65% year-over-year to $103.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $171.2 million (up 4.52% YoY) and the FY2025 annual result came in at $91.0 million, down 25.49% from the prior year.
• Change in Accured Expenses was $103.9 million for Q1 2026 at Resmed, up from $10.6 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $122.0 million in Q2 2024 and bottomed at -$34.4 million in Q4 2023.
• A 5-year average of $25.0 million and a median of $10.6 million in 2025 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 36862.42% in 2024, while the deepest fall reached 2399.02% in 2024.
• Resmed's Change in Accured Expenses stood at -$17.3 million in 2022, then sank by 99.02% to -$34.4 million in 2023, then surged by 112.28% to $4.2 million in 2024, then jumped by 152.25% to $10.6 million in 2025, then soared by 875.82% to $103.9 million in 2026.
• Business Quant data shows RMD's Change in Accured Expenses at $103.9 million in Q1 2026, $10.6 million in Q4 2025, and $7.6 million in Q3 2025.